{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T20:25:46Z","timestamp":1774556746341,"version":"3.50.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004391","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU102-PH-01"],"award-info":[{"award-number":["CMU102-PH-01"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU100-S-01"],"award-info":[{"award-number":["CMU100-S-01"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-105-031"],"award-info":[{"award-number":["DMR-105-031"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-105-098"],"award-info":[{"award-number":["DMR-105-098"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-106-155"],"award-info":[{"award-number":["DMR-106-155"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 103-2320-B-039-006-MY3"],"award-info":[{"award-number":["MOST 103-2320-B-039-006-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 105-2314-B-039-037-MY3"],"award-info":[{"award-number":["MOST 105-2314-B-039-037-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 106-2320-B-039-017-MY3"],"award-info":[{"award-number":["MOST 106-2320-B-039-017-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01004","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T05:20:05Z","timestamp":1536038405000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of Oral Antiretroviral Drugs in Mice With Metabolic and Neurologic Complications"],"prefix":"10.3389","volume":"9","author":[{"given":"Fuu-Jen","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Wang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Ho","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Hsing","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Pi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Fung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Chang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsinyi","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Hsu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiu-Chu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-Mei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Liang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Miin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/QAI.0b013e318042d5fe","article-title":"Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens.","volume":"45","author":"Anastos","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"B2","first-page":"104","article-title":"Neuropharmacological effects of Nigella sativa.","volume":"6","author":"Beheshti","year":"2016","journal-title":"Avicenna J. Phytomed."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095500","article-title":"Efavirenz promotes beta-secretase expression and increased Abeta1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND).","volume":"9","author":"Brown","year":"2014","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1097\/00002030-200411050-00004","article-title":"The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro.","volume":"18","author":"Caron","year":"2004","journal-title":"AIDS"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s13365-015-0404-5","article-title":"Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study.","volume":"22","author":"Carvalhal","year":"2016","journal-title":"J. Neurovirol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2165\/00002018-200629100-00004","article-title":"Neuropsychiatric complications of antiretroviral therapy.","volume":"29","author":"Cespedes","year":"2006","journal-title":"Drug Saf."},{"key":"B8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.brainres.2009.04.002","article-title":"Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action.","volume":"1273","author":"Chen","year":"2009","journal-title":"Brain Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/ijo.2016.189","article-title":"The role and possible mechanism of lncRNA U90926 in modulating 3T3-L1 preadipocyte differentiation.","volume":"41","author":"Chen","year":"2017","journal-title":"Int. J. Obes."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1212\/WNL.0b013e31821670fb","article-title":"Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.","volume":"76","author":"Ciccarelli","year":"2011","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease.","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"B12","first-page":"171","article-title":"Thiazolidinediones in the treatment of HIV\/HAART-associated lipodystrophy syndrome.","volume":"15","author":"Edgeworth","year":"2013","journal-title":"AIDS Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3851\/IMP2926","article-title":"Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility.","volume":"20","author":"Fabbiani","year":"2015","journal-title":"Antivir. Ther."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.18.1.19033","article-title":"HIV\/AIDS and lipodystrophy: implications for clinical management in resource-limited settings.","volume":"18","author":"Finkelstein","year":"2015","journal-title":"J. Int. AIDS Soc."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-4-23","article-title":"Antiretroviral medications disrupt microglial phagocytosis of beta-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders.","volume":"4","author":"Giunta","year":"2011","journal-title":"Mol. Brain"},{"key":"B16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/135965350400900206","article-title":"Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.","volume":"9","author":"Gougeon","year":"2004","journal-title":"Antivir. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.antiviral.2012.04.010","article-title":"Brain injury caused by HIV protease inhibitors: role of lipodystrophy and insulin resistance.","volume":"95","author":"Gupta","year":"2012","journal-title":"Antiviral Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.coph.2007.10.006","article-title":"Leptin regulation of neuronal excitability and cognitive function.","volume":"7","author":"Harvey","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"20015","DOI":"10.1074\/jbc.M802187200","article-title":"SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase.","volume":"283","author":"Hou","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.biopha.2008.09.015","article-title":"The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.","volume":"63","author":"Jevtovic","year":"2009","journal-title":"Biomed. Pharmacother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3727\/096368916X691457","article-title":"HIV non-nucleoside reverse transcriptase inhibitor efavirenz reduces neural stem cell proliferation in vitro and in vivo.","volume":"25","author":"Jin","year":"2016","journal-title":"Cell Transplant."},{"key":"B23","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1468-1293.2005.00325.x","article-title":"Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.","volume":"6","author":"Jones","year":"2005","journal-title":"HIV Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI1411","article-title":"Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1\/SREBP1.","volume":"101","author":"Kim","year":"1998","journal-title":"J. Clin. Invest."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/srep14762","article-title":"Genetic variants in PLCB4\/PLCB1 as susceptibility loci for coronary artery aneurysm formation in Kawasaki disease in Han Chinese in Taiwan.","volume":"5","author":"Lin","year":"2015","journal-title":"Sci. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s13365-015-0382-7","article-title":"Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.","volume":"22","author":"Ma","year":"2016","journal-title":"J. Neurovirol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1210\/endo.139.3.5792","article-title":"Regulation of leptin promoter function by Sp1. C\/EBP, and a novel factor.","volume":"139","author":"Mason","year":"1998","journal-title":"Endocrinology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3851\/IMP3101","article-title":"Hyperlipidaemia in HIV-infected patients on lopinavir\/ritonavir monotherapy in resource-limited settings.","volume":"22","author":"Matoga","year":"2017","journal-title":"Antivir. Ther."},{"key":"B29","first-page":"298","article-title":"Food for thought: leptin regulation of hippocampal function and its role in Alzheimer\u2019s disease.","author":"McGregor","year":"","journal-title":"Neuropharmacology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-017-2362-1","article-title":"Leptin regulation of synaptic function at hippocampal TA-CA1 and SC-CA1 synapses: implications for health and disease.","author":"McGregor","year":"","journal-title":"Neurochem. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","article-title":"Visceral abdominal-fat accumulation associated with use of indinavir.","volume":"351","author":"Miller","year":"1998","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116297","article-title":"A randomized comparative trial of continued abacavir\/lamivudine plus efavirenz or replacement with efavirenz\/emtricitabine\/tenofovir DF in hypercholesterolemic HIV-1 infected individuals.","volume":"10","author":"Moyle","year":"2015","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1210\/jc.2008-1588","article-title":"The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia.","volume":"94","author":"Mulligan","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1086\/367859","article-title":"Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin.","volume":"36","author":"Nagy","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6405-10-32","article-title":"Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects.","volume":"10","author":"Paula","year":"2013","journal-title":"AIDS Res. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/hiv.12298","article-title":"Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: the RELAX study.","volume":"16","author":"Pedrol","year":"2015","journal-title":"HIV Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.antiviral.2010.10.006","article-title":"Metabolic and neurologic consequences of chronic lopinavir\/ritonavir administration to C57BL\/6 mice.","volume":"88","author":"Pistell","year":"2010","journal-title":"Antiviral Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1128\/AAC.00625-06","article-title":"Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice.","volume":"50","author":"Prot","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited.","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12640-009-9141-y","article-title":"Anti-HIV drugs nevirapine and efavirenz affect anxiety-related behavior and cognitive performance in mice.","volume":"19","author":"Romao","year":"2011","journal-title":"Neurotox. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.cellbio.16.1.145","article-title":"Molecular regulation of adipogenesis.","volume":"16","author":"Rosen","year":"2000","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s13365-017-0573-5","article-title":"Central nervous system-penetrating antiretrovirals impair energetic reserve in striatal nerve terminals.","volume":"23","author":"Stauch","year":"2017","journal-title":"J. Neurovirol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(05)60295-4","article-title":"\u201cBuffalo hump\u201d in HIV-1 infection.","volume":"352","author":"Stocker","year":"1998","journal-title":"Lancet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1007\/s11064-011-0432-3","article-title":"Non-nucleoside reverse transcriptase inhibitors efavirenz and nevirapine inhibit cytochrome C oxidase in mouse brain regions.","volume":"36","author":"Streck","year":"2011","journal-title":"Neurochem. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"92","DOI":"10.11599\/germs.2015.1076","article-title":"Leptin expression in HIV-infected patients during antiretroviral therapy.","volume":"5","author":"Tiliscan","year":"2015","journal-title":"Germs"},{"key":"B46","doi-asserted-by":"publisher","first-page":"106369","DOI":"10.18632\/oncotarget.22465","article-title":"Effect of antiretroviral therapy use and adherence on the risk of hyperlipidemia among HIV-infected patients, in the highly active antiretroviral therapy era.","volume":"8","author":"Tsai","year":"2017","journal-title":"Oncotarget"},{"key":"B47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.metabol.2014.07.017","article-title":"Leptin in congenital and HIV-associated lipodystrophy.","volume":"64","author":"Tsoukas","year":"2015","journal-title":"Metabolism"},{"key":"B48","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/cid\/ciw395","article-title":"Switching lopinavir\/ritonavir to atazanavir\/ritonavir vs adding atorvastatin in HIV-Infected patients receiving second-line antiretroviral therapy with hypercholesterolemia: a randomized controlled trial.","volume":"63","author":"Wangpatharawanit","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.2337\/db05-1188","article-title":"Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice.","volume":"55","author":"Zang","year":"2006","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B50","doi-asserted-by":"publisher","first-page":"47898","DOI":"10.1074\/jbc.M408149200","article-title":"AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells.","volume":"279","author":"Zang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1210\/jcem.84.11.6234","article-title":"Inhibition of adipocyte differentiation by HIV protease inhibitors.","volume":"84","author":"Zhang","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01004\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T11:56:13Z","timestamp":1661946973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01004\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":51,"alternative-id":["10.3389\/fphar.2018.01004"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01004","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"article-number":"1004"}}